2018
Overview
Cancer genomics is an emerging field of oncology research that focuses on the study of genetic mutations in cancer cells. These mutations can provide important insights into the causes, progression, and treatment of various types of cancer. In cancer genomics research, scientists use advanced sequencing technologies to rapidly sequence the entire genome or specific regions of DNA from cancer cells. This enables them to identify genetic mutations that are unique to cancer cells and not found in normal cells. By analyzing the genetic mutations present in cancer cells, researchers can gain a better understanding of the molecular mechanisms underlying cancer development and progression. This can potentially lead to the identification of new targets for cancer therapies that are more precise and effective. Cancer genomics research is also helping to pave the way for precision medicine, which involves tailoring treatments to the specific genetic makeup of individual patients. By identifying the genetic mutations that are driving a patient's cancer, doctors can develop personalized treatment plans that are more effective than one-size-fits-all therapies. Overall, cancer genomics research is a rapidly evolving field that holds great promise for improving cancer diagnosis, treatment, and prevention. As technology continues to advance, we can expect to see even more exciting developments in this field in the years to come.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.
How this research is being cited
The 1 article above has been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.
-
2018 · Journal of Proteomics and Genomics research
A sample of recent works citing this journal's research on Cancer Genomics, linking to each citing work.